Medicamen Biotech informs about outcome of board meeting

12 Sep 2022 Evaluate
Medicamen Biotech has informed that the Board of Directors of the Company, at their meeting held today, September 12, 2022 at 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi-110019h has considered and approved the following businesses: Allotment of 4,34,500 Equity Share for cash at an issue price of Rs 709 per Equity Share by way of preferential allotment;  Allotment of 63,500 Fully Convertible Warrants ('Warrants') each carrying a right to subscribe to one Equity Share per Warrant, for cash at an issue price of Rs 709 per warrant by way of preferential allotment.

The above information is a part of company’s filings submitted to BSE.


Medicamen Biotech Share Price

495.05 14.50 (3.02%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.